<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <title>PromptGenix – SBIR BioAI Automation Platform</title>
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <style>
    * { box-sizing: border-box; }

    body {
      margin: 0;
      font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", sans-serif;
      background: #020617;
      color: #e5e7eb;
      line-height: 1.5;
    }

    a { color: inherit; text-decoration: none; }

    .page {
      min-height: 100vh;
      display: flex;
      flex-direction: column;
    }

    header {
      position: sticky;
      top: 0;
      z-index: 20;
      backdrop-filter: blur(14px);
      background: rgba(15, 23, 42, 0.92);
      border-bottom: 1px solid rgba(148, 163, 184, 0.3);
    }

    .nav {
      max-width: 1120px;
      margin: 0 auto;
      padding: 14px 20px;
      display: flex;
      align-items: center;
      justify-content: space-between;
      gap: 24px;
    }

    .nav-left {
      display: flex;
      align-items: center;
      gap: 12px;
    }

    .logo-dot {
      width: 28px;
      height: 28px;
      border-radius: 999px;
      background: radial-gradient(circle at 0 0,#38bdf8,#8b5cf6);
      box-shadow: 0 0 18px rgba(56,189,248,.7);
    }

    .brand {
      font-size: 1.1rem;
      font-weight: 650;
      letter-spacing: 0.04em;
    }

    .nav-links {
      display: flex;
      gap: 18px;
      font-size: .9rem;
      color: #9ca3af;
    }

    .nav-links a {
      padding: 6px 10px;
      border-radius: 999px;
    }

    .nav-links a.active,
    .nav-links a:hover {
      color: #e5e7eb;
      background: rgba(148, 163, 184, 0.18);
    }

    .nav-cta {
      display: flex;
      gap: 10px;
      align-items: center;
    }

    .btn {
      border-radius: 999px;
      border: 1px solid rgba(148, 163, 184, 0.6);
      padding: 8px 14px;
      font-size: .85rem;
      cursor: pointer;
      background: transparent;
      color: #e5e7eb;
    }

    .btn-primary {
      border: none;
      background: linear-gradient(135deg,#22c55e,#22d3ee,#6366f1);
      color: #020617;
      font-weight: 600;
      box-shadow: 0 0 22px rgba(59,130,246,0.55);
    }

    .btn-primary:hover {
      filter: brightness(1.05);
    }

    .btn-outline:hover {
      background: rgba(148, 163, 184, 0.24);
    }

    main {
      flex: 1;
    }

    .section {
      max-width: 1120px;
      margin: 0 auto;
      padding: 40px 20px 32px;
    }

    /* HERO */
    .hero {
      padding-top: 42px;
      padding-bottom: 32px;
      display: grid;
      grid-template-columns: minmax(0, 1.25fr) minmax(0, 1.1fr);
      gap: 42px;
      align-items: center;
    }

    .badge-row {
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
      margin-bottom: 14px;
    }

    .badge {
      font-size: .7rem;
      text-transform: uppercase;
      letter-spacing: .12em;
      border-radius: 999px;
      padding: 5px 11px;
      border: 1px solid rgba(251,191,36,0.6);
      color: #fed7aa;
      background: rgba(120,53,15,0.4);
    }

    .hero-title {
      font-size: clamp(2.2rem, 3vw + 1.5rem, 3rem);
      font-weight: 750;
      letter-spacing: 0.01em;
      color: #f9fafb;
      margin-bottom: 16px;
    }

    .hero-subtitle {
      font-size: 1.02rem;
      color: #e5e7eb;
      max-width: 34rem;
      margin-bottom: 22px;
    }

    .hero-subnote {
      font-size: .8rem;
      color: #9ca3af;
      margin-top: 6px;
      max-width: 32rem;
    }

    .hero-ctas {
      display: flex;
      flex-wrap: wrap;
      gap: 12px;
      align-items: center;
      margin-top: 14px;
    }

    .hero-right-card {
      border-radius: 18px;
      padding: 18px 18px 16px;
      background: radial-gradient(circle at 0 0,#0f172a,#020617 50%,#020617 100%);
      border: 1px solid rgba(148, 163, 184, 0.4);
      box-shadow: 0 20px 40px rgba(15,23,42,0.9);
    }

    .hero-right-title {
      font-size: .86rem;
      text-transform: uppercase;
      letter-spacing: .16em;
      color: #a5b4fc;
      margin-bottom: 8px;
    }

    .hero-right-main {
      font-size: 1.05rem;
      font-weight: 600;
      margin-bottom: 8px;
    }

    .hero-right-body {
      font-size: .88rem;
      color: #cbd5f5;
      margin-bottom: 12px;
    }

    .hero-right-pill-row {
      display: flex;
      flex-wrap: wrap;
      gap: 6px;
      margin-top: 6px;
    }

    .pill {
      font-size: .7rem;
      padding: 4px 7px;
      border-radius: 999px;
      background: rgba(15,23,42,0.9);
      border: 1px solid rgba(129,140,248,0.5);
      color: #c7d2fe;
    }

    /* Two-column descriptive section */
    .two-col {
      display: grid;
      grid-template-columns: minmax(0, 1.2fr) minmax(0, 1fr);
      gap: 32px;
      align-items: flex-start;
      margin-top: 8px;
    }

    .section-kicker {
      font-size: .78rem;
      text-transform: uppercase;
      letter-spacing: .18em;
      color: #a5b4fc;
      margin-bottom: 4px;
    }

    .section-title {
      font-size: 1.45rem;
      font-weight: 650;
      margin-bottom: 8px;
      color: #f9fafb;
    }

    .section-text {
      font-size: .93rem;
      color: #d1d5db;
    }

    ul {
      padding-left: 1.1rem;
      margin: .4rem 0 0;
      font-size: .9rem;
      color: #d1d5db;
    }

    li { margin-bottom: 4px; }

    .callout {
      border-radius: 14px;
      padding: 12px 14px;
      border: 1px dashed rgba(148, 163, 184, 0.5);
      background: rgba(15,23,42,0.8);
      font-size: .86rem;
      color: #e5e7eb;
      margin-top: 10px;
    }

    .callout strong { color: #22c55e; }

    /* Use case image section */
    .usecase-img {
      width: 100%;
      max-width: 980px;
      border-radius: 16px;
      display: block;
      margin: 24px auto 0;
      box-shadow: 0 18px 45px rgba(15,23,42,0.9);
    }

    .tag-row {
      margin-top: 10px;
      display: flex;
      flex-wrap: wrap;
      gap: 8px;
      font-size: .78rem;
      color: #9ca3af;
    }

    .tag-row span {
      padding: 4px 10px;
      border-radius: 999px;
      border: 1px solid rgba(75,85,99,0.9);
      background: rgba(15,23,42,0.9);
    }

<!-- EVIDENCE / FEASIBILITY -->
<section class="section" id="evidence">
  <div class="two-col">
    <div>
      <div class="section-kicker">Evidence & Feasibility</div>
      <h2 class="section-title">Technically feasible today, scalable in Phase I.</h2>
      <p class="section-text">
        PromptGenix builds on proven bioinformatics pipelines and a literature-aware LLM layer.
        Phase I focuses on integration, robustness, and measurable performance gains using public datasets.
      </p>

      <ul>
        <li><strong>Automated pipelines:</strong> RNA-Seq (QC → alignment → DEG → GSEA/GSVA) and flow cytometry preprocessing and analysis are already functional in prototype form.</li>
        <li><strong>LLM-driven interpretation:</strong> Internal LLM produces structured summaries, ranked hypotheses, and concrete validation experiments.</li>
        <li><strong>Reproducibility:</strong> Deterministic configs, versioned outputs, and exportable HTML/PDF reports.</li>
      </ul>

      <div class="callout">
        <strong>Public-data validation:</strong> Phase I evaluation will use GEO, SRA, and FlowRepository datasets only,
        ensuring no IP or data-use conflicts.
      </div>
    </div>

    <div>
      <div class="section-kicker">Phase I Deliverables</div>
      <h2 class="section-title">Clear milestones with measurable KPIs.</h2>

      <ul>
        <li><strong>D1.</strong> End-to-end automated RNA-Seq and flow cytometry pipelines hardened on ≥3 public datasets.</li>
        <li><strong>D2.</strong> Hypothesis Generator producing ranked hypotheses and experiment suggestions with traceable PubMed citations.</li>
        <li><strong>D3.</strong> Reviewer-ready HTML/PDF reports generated in &lt;24 hours from raw data.</li>
      </ul>

      <div class="callout">
        <strong>Success metrics (examples):</strong>
        <ul>
          <li>≥70% reduction in analysis turnaround time vs. manual workflows</li>
          <li>≥90% pipeline reproducibility across reruns</li>
          <li>≥80% user-rated usefulness of AI-generated hypotheses (pilot feedback)</li>
        </ul>
      </div>
    </div>
  </div>
</section>
    
    /* Team + Pilot grid */
    .grid-2 {
      display: grid;
      grid-template-columns: minmax(0, 1.05fr) minmax(0, 1.05fr);
      gap: 24px;
      margin-top: 16px;
    }

    .card {
      border-radius: 16px;
      padding: 16px 18px;
      background: rgba(15,23,42,0.96);
      border: 1px solid rgba(55,65,81,0.9);
    }

    .card h3 {
      margin: 0 0 8px;
      font-size: 1.05rem;
      color: #e5e7eb;
    }

    .card p {
      font-size: .9rem;
      color: #d1d5db;
      margin: 4px 0 8px;
    }

    .small {
      font-size: .8rem;
      color: #9ca3af;
    }

    footer {
      border-top: 1px solid rgba(31,41,55,0.9);
      padding: 16px 20px 22px;
      font-size: .78rem;
      color: #6b7280;
      text-align: center;
      background: #020617;
    }

    @media (max-width: 880px) {
      .hero {
        grid-template-columns: minmax(0,1fr);
      }
      .two-col {
        grid-template-columns: minmax(0,1fr);
      }
      .grid-2 {
        grid-template-columns: minmax(0,1fr);
      }
      .nav {
        flex-wrap: wrap;
      }
      .nav-links {
        width: 100%;
        justify-content: center;
      }
    }
  </style>
</head>
<body>
<div class="page">

  <!-- HEADER -->
  <header>
    <div class="nav">
      <div class="nav-left">
        <div class="logo-dot"></div>
        <div>
          <div class="brand">PromptGenix</div>
          <div style="font-size:.72rem;color:#9ca3af;">BioAI Automation Platform</div>
        </div>
      </div>

      <nav class="nav-links">
        <a href="index.html" class="active">SBIR Landing</a>
        <a href="use-cases.html">Use Cases</a>
        <a href="#team">Team</a>
        <a href="#pilot">Pilot Program</a>
      </nav>

      <div class="nav-cta">
        <a class="btn btn-outline" href="mailto:dohoon.kim1@icloud.com?subject=PromptGenix%20SBIR%20Inquiry">
          Email us
        </a>
      </div>
    </div>
  </header>

  <main>

    <!-- HERO -->
    <section class="section hero">
      <div>
        <div class="badge-row">
          <span class="badge">Women & Minority-Owned BioAI</span>
          <span class="badge" style="border-color:rgba(56,189,248,0.7);color:#bae6fd;background:rgba(15,23,42,0.9);">
            NIH / NIAID SBIR-ready
          </span>
        </div>

        <h1 class="hero-title">
          Automated RNA-Seq & Flow Cytometry analysis, with an AI co-investigator.
        </h1>

        <p class="hero-subtitle">
          PromptGenix turns FASTQ and FCS files into reproducible pipelines, 
          human-readable scientific summaries, and even <strong>new hypotheses and follow-up experiments</strong>.
        </p>

        <div class="hero-ctas">
          <a class="btn btn-primary" href="#pilot">Request a pilot</a>
          <a class="btn btn-outline" href="use-cases.html">View analysis examples</a>
        </div>

        <p class="hero-subnote">
          Built by an immunology & bioinformatics PI with 10+ years of HIV, vaccine, and flow cytometry experience.
          Deployed securely on local Mac Studio or AWS.
        </p>
      </div>

      <!-- Hypothesis Generator highlight -->
      <div class="hero-right-card">
        <div class="hero-right-title">AI HYPOTHESIS GENERATOR</div>
        <div class="hero-right-main">
          Literature-aware LLM that proposes testable hypotheses, not just summaries.
        </div>
        <div class="hero-right-body">
          PromptGenix uses an internal LLM fine-tuned for immunology and omics to:
        </div>
        <ul>
          <li>Scan PubMed and domain knowledge for mechanisms related to the uploaded dataset</li>
          <li>Generate <strong>high-confidence biological hypotheses</strong></li>
          <li>Recommend concrete follow-up experiments (flow panels, RNA-Seq contrasts, scRNA-Seq subsets)</li>
        </ul>
        <div class="hero-right-pill-row">
          <span class="pill">PubMed-aware reasoning</span>
          <span class="pill">Hypothesis ranking</span>
          <span class="pill">Experiment suggestions</span>
        </div>
      </div>
    </section>

    <!-- PROBLEM / SOLUTION / INNOVATION -->
    <section class="section">
      <div class="two-col">
        <div>
          <div class="section-kicker">The problem</div>
          <h2 class="section-title">Terabytes of omics data, but insights arrive too late.</h2>
          <p class="section-text">
            Modern immunology and genomics programs collect huge volumes of RNA-Seq, scRNA-Seq, and flow cytometry data,
            but analysis often depends on fragmented tools, custom scripts, and a handful of over-extended experts.
            Turnaround is measured in weeks, not hours, and every project feels like a one-off.
          </p>
          <ul>
            <li>Multiple disconnected tools (STAR, RSEM, Seurat, FlowJo, COMPASS, GSEA)</li>
            <li>Siloed code that is hard to reuse and harder to maintain</li>
            <li>Limited access to biostatistics and bioinformatics expertise</li>
            <li>Scientific interpretation left to whoever has time to read the literature</li>
          </ul>
        </div>

        <div>
          <div class="section-kicker">PromptGenix solution</div>
          <h2 class="section-title">An end-to-end BioAI co-pilot for analysis, interpretation, and hypothesis.</h2>
          <p class="section-text">
            PromptGenix automates QC, alignment, DEG, GSEA/GSVA, and flow cytometry gating in reproducible pipelines.
            On top of that, our internal LLM layer reads the results, cross-references the literature, and proposes
            mechanistic hypotheses and validation experiments that can be dropped into a grant or lab meeting slide.
          </p>
          <ul>
            <li>One-click pipelines for RNA-Seq, scRNA-Seq, and flow cytometry</li>
            <li>Exportable HTML/PDF reports with plain-language summaries</li>
            <li>Configurable to run entirely on-prem (Mac Studio) or in a secure AWS VPC</li>
          </ul>
          <div class="callout">
            <strong>SBIR focus:</strong> Phase I will harden the automated pipelines and hypothesis generator
            on public datasets, then apply them to partner HIV/vaccine cohorts to demonstrate impact on study design.
          </div>
        </div>
      </div>
    </section>

    <!-- USE CASE VISUAL -->
    <section class="section">
      <div class="section-kicker">What it does today</div>
      <h2 class="section-title">From dimensionality reduction to gene set enrichment.</h2>
      <p class="section-text">
        The current PromptGenix prototype already automates core workflows used in NIH-funded labs.
        Below is an example of the types of analyses our pipelines and LLM layer can generate and explain.
      </p>

      <img
        src="assets/img/usecases/usecases_main.png"
        alt="PromptGenix dimensionality reduction, differential expression, immune signatures, cell subset gating, gene set enrichment and team comparison use cases"
        class="usecase-img"
      />

      <div class="tag-row">
        <span>UMAP / t-SNE</span>
        <span>Differential expression</span>
        <span>Immune signatures</span>
        <span>Cell subset gating</span>
        <span>Gene set enrichment</span>
        <span>Team vs. team analysis</span>
      </div>
    </section>

    <!-- TEAM & PILOT -->
    <section class="section" id="team">
      <div class="grid-2">
        <div class="card">
          <div class="section-kicker">Team</div>
          <h3>Women & minority-owned BioAI startup with deep immunology experience.</h3>
          <p class="small">
            PromptGenix is intentionally structured to qualify for women-owned and minority-owned small business
            programs while bringing PI-level domain expertise to AI-driven analysis.
          </p>
          <p><strong>Yon Ji – CEO</strong><br/>
            Leads operations, compliance, and business strategy. As a woman founder, she anchors PromptGenix
            as a women-owned, minority-owned small business positioned for SBIR and related set-aside programs.
          </p>
          <p><strong>Dohoon Kim, MS – CTO & Founder</strong><br/>
            Immunology and bioinformatics scientist with 10+ years at WRAIR/MHRP, specializing in HIV, vaccine trials,
            RNA-Seq, scRNA-Seq, COMPASS, and high-dimensional flow cytometry. Architect of the PromptGenix pipelines
            and LLM-driven interpretation engine.
          </p>
          <p class="small">
            Phase I will also establish an advisory board of collaborating PIs to provide real-world datasets and
            feedback on usability.
          </p>
        </div>

        <div class="card" id="pilot">
          <div class="section-kicker">Pilot program</div>
          <h3>We are seeking 2–3 SBIR partner labs for structured pilots.</h3>
          <p>
            For Phase I, PromptGenix will onboard a small number of HIV, vaccine, or infectious disease labs as
            pilot sites. We will run our pipelines and hypothesis generator on public or de-identified datasets and
            measure impact on turnaround time, interpretability, and study design decisions.
          </p>
          <ul>
            <li>Upload FASTQ / FCS files or point to public GEO / FlowRepository accessions</li>
            <li>Receive a reproducible pipeline plus LLM-generated report and hypothesis list</li>
            <li>Provide structured feedback to refine usability and scientific value</li>
          </ul>
          <p class="small">
            Interested in being a pilot lab or letter-of-support partner? Contact us using the button below.
          </p>
          <a class="btn btn-primary"
             href="mailto:dohoon.kim1@icloud.com?subject=PromptGenix%20Pilot%20Program&body=I%27m%20interested%20in%20participating%20in%20the%20PromptGenix%20pilot.%20Please%20follow%20up%20with%20details.">
            Contact PromptGenix about a pilot
          </a>
        </div>
      </div>
    </section>

  </main>

  <footer>
    PromptGenix &middot; Women & Minority-Owned BioAI Automation Platform &middot;
    Contact: <a href="mailto:dohoon.kim1@icloud.com">dohoon.kim1@icloud.com</a>
  </footer>
</div>
</body>
</html>
